Related Experiment Video
Updated: Jun 6, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have
Takashi Kanou1, Chitose Oneyama, Kunimitsu Kawahara
1Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University. 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
Abstract:
The tyrosine kinase c-Src is upregulated in various human cancers, although the precise regulatory mechanism underlying this upregulation is unclear. We previously reported that a transmembrane adaptor Csk-binding protein (Cbp; PAG1) plays an important role in controlling the cell transformation that is induced by the activation of c-Src. To elucidate the in vivo role of Cbp, we examined the function of Cbp in lung cancer cell lines and tissues. In this study, we found that Cbp was markedly downregulated in human non-small cell lung cancer (NSCLC) cells. The ectopic expression of Cbp suppressed the anchorage-independent growth of the NSCLC cell lines (A549 and Lu99) that had upregulated c-Src, whereas the Cbp expression had little effect on other NSCLC cell lines (PC9 and Lu65) that express normal levels of c-Src. The expression of Cbp suppressed the kinase activity of c-Src in A549 cells by recruiting c-Src and its negative regulator, C-terminal Src kinase (Csk), to lipid rafts. The treatment with Src inhibitors, such as PP2, dasatinib, and saracatinib, also suppressed the growth of A549 cells. Furthermore, Cbp expression attenuated the ability of A549 cells to form tumors in nude mice, invade in vitro, and metastasize in vivo. In addition, we found a significant inverse correlation between the level of Cbp expression and the extent of lymph node metastasis in human lung cancers. These results indicate that Cbp is required for the Csk-mediated inactivation of c-Src and may control the promotion of malignancy in NSCLC tumors that are characterized by c-Src upregulation.
Insights
Csk-binding protein (Cbp) downregulation promotes non-small cell lung cancer (NSCLC) malignancy by enabling c-Src activation. Restoring Cbp suppresses tumor growth, invasion, and metastasis, highlighting Cbp as a potential therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The tyrosine kinase c-Src is frequently upregulated in human cancers, contributing to malignancy.
- The precise mechanisms regulating c-Src upregulation in cancer remain incompletely understood.
- Csk-binding protein (Cbp; PAG1) has been implicated in controlling c-Src-induced cell transformation.
Purpose of the Study:
- To investigate the in vivo role of Csk-binding protein (Cbp) in non-small cell lung cancer (NSCLC).
- To determine the functional impact of Cbp expression on NSCLC cell behavior and tumor progression.
- To elucidate the molecular mechanisms by which Cbp influences c-Src activity in lung cancer.
Main Methods:
- Analysis of Cbp expression levels in human NSCLC cell lines and tissues.
- Ectopic expression of Cbp in NSCLC cell lines with varying c-Src activity.
- Assessment of anchorage-independent growth, tumor formation in nude mice, in vitro invasion, and in vivo metastasis.
- Investigation of c-Src kinase activity and recruitment of Csk to lipid rafts upon Cbp expression.
- Correlation analysis between Cbp expression and lymph node metastasis in human lung cancer patients.
Main Results:
- Cbp expression was markedly downregulated in human NSCLC cells.
- Ectopic Cbp expression suppressed anchorage-independent growth in NSCLC cells with upregulated c-Src.
- Cbp expression reduced c-Src kinase activity by facilitating the recruitment of c-Src and Csk to lipid rafts.
- Cbp expression attenuated tumor formation, invasion, and metastasis in preclinical models.
- A significant inverse correlation was observed between Cbp levels and lymph node metastasis in human lung cancers.
Conclusions:
- Cbp downregulation is associated with enhanced malignancy in NSCLC.
- Cbp plays a critical role in Csk-mediated inactivation of c-Src.
- Cbp functions as a tumor suppressor by inhibiting c-Src-driven oncogenesis in NSCLC.
- Cbp represents a potential therapeutic target for managing NSCLC characterized by c-Src upregulation.
More Related Videos
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
